Trial Profile
Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jul 2017
Price :
$35
*
At a glance
- Drugs Peginterferon (Primary) ; Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 10 Jul 2017 New trial record